Variant report
Variant | nsv968900 |
---|---|
Chromosome Location | chr5:29351982-29388766 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:16)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29374107..29376875-chr5:29377791..29380634,2 | K562 | blood: | |
2 | chr5:29367229..29368191-chr5:29697633..29698544,4 | MCF-7 | breast: | |
3 | chr5:29374107..29376875-chr5:29377791..29380634,2 | K562 | blood: | |
4 | chr5:29367263..29368784-chr5:29811787..29812627,6 | MCF-7 | breast: | |
5 | chr5:29367148..29368248-chr5:29697562..29698574,8 | MCF-7 | breast: | |
6 | chr5:29367557..29368187-chr5:29811640..29812581,2 | MCF-7 | breast: |
(count:16 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DROSHA-7 | chr5:29384427-29384499 | NR_104628 |
2 | lnc-DROSHA-7 | chr5:29363459-29363489 | XLOC_004765 |
3 | lnc-DROSHA-7 | chr5:29381960-29382069 | XLOC_004765 |
4 | lnc-DROSHA-7 | chr5:29380373-29380432 | XLOC_004765 |
5 | lnc-DROSHA-7 | chr5:29380403-29380432 | XLOC_004765 |
6 | lnc-DROSHA-7 | chr5:29384427-29384499 | XLOC_004765 |
7 | lnc-DROSHA-7 | chr5:29381960-29382069 | XLOC_004765 |
8 | lnc-DROSHA-7 | chr5:29381960-29382069 | XLOC_004765 |
9 | lnc-DROSHA-7 | chr5:29383211-29383410 | XLOC_004765 |
10 | lnc-DROSHA-7 | chr5:29384427-29384499 | XLOC_004765 |
11 | lnc-DROSHA-7 | chr5:29380196-29380432 | NR_104628 |
12 | lnc-DROSHA-7 | chr5:29381960-29382069 | NR_104628 |
13 | lnc-DROSHA-7 | chr5:29384404-29384499 | XLOC_004765 |
14 | lnc-DROSHA-7 | chr5:29384427-29384499 | XLOC_004765 |
15 | lnc-DROSHA-7 | chr5:29384404-29384499 | XLOC_004765 |
16 | lnc-DROSHA-7 | chr5:29355912-29356069 | XLOC_004765 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SGMS1 | miRNA target sites |
DGKA | miRNA target sites |
AGK | miRNA target sites |
AGPAT3 | miRNA target sites |
SERPINB2 | miRNA target sites |
AGL | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188524092 | chr5:29355932-29355933 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs62621192 | chr5:29355963-29355964 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs370795228 | chr5:29355992-29355993 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs149582832 | chr5:29356008-29356009 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs192728627 | chr5:29356040-29356041 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs147609761 | chr5:29367412-29367413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368562737 | chr5:29367423-29367424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7717754 | chr5:29367435-29367436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187327459 | chr5:29367445-29367446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7717780 | chr5:29367474-29367475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs71621784 | chr5:29367480-29367481 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs542483511 | chr5:29367497-29367498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11956788 | chr5:29367501-29367502 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs536515886 | chr5:29367509-29367510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543214021 | chr5:29367512-29367513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543283733 | chr5:29367528-29367529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191694106 | chr5:29367560-29367561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182931262 | chr5:29367562-29367563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150668496 | chr5:29367563-29367564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375894084 | chr5:29367565-29367566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547503811 | chr5:29367594-29367595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147067157 | chr5:29367599-29367600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145232668 | chr5:29367606-29367607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529736831 | chr5:29367626-29367627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149139458 | chr5:29367644-29367645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567971186 | chr5:29367647-29367648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17617805 | chr5:29367711-29367712 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs554952035 | chr5:29367817-29367818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187473782 | chr5:29367850-29367851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12520476 | chr5:29367876-29367877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554260278 | chr5:29367914-29367915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376575653 | chr5:29367951-29367952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115247645 | chr5:29367994-29367995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536254571 | chr5:29368005-29368006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554394521 | chr5:29368007-29368008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs16898904 | chr5:29368024-29368025 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
37 | rs573112739 | chr5:29368045-29368046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs193260141 | chr5:29368075-29368076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185376431 | chr5:29368120-29368121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540741718 | chr5:29368129-29368130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559414304 | chr5:29368147-29368148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540761462 | chr5:29368177-29368178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541850148 | chr5:29368181-29368182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369637022 | chr5:29368186-29368187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527706800 | chr5:29368193-29368194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536439176 | chr5:29380228-29380229 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs554516598 | chr5:29380266-29380267 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs368815131 | chr5:29380287-29380288 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs537214527 | chr5:29380295-29380296 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs576068287 | chr5:29380325-29380326 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29367400-29367800 | Enhancers | Brain Cingulate Gyrus | brain |
2 | chr5:29367400-29368000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:29367400-29368200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr5:29382600-29383200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr5:29382600-29383200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr5:29383000-29383400 | Active TSS | HepG2 | liver |